Literature DB >> 2157037

Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens.

J Taylor1, C Edbauer, A Rey-Senelonge, J F Bouquet, E Norton, S Goebel, P Desmettre, E Paoletti.   

Abstract

A cDNA copy of the RNA encoding the fusion (F) protein of Newcastle disease virus (NDV) strain Texas, a velogenic strain of NDV, was obtained and the sequence was determined. The 1,792-base-pair sequence encodes a protein of 553 amino acids which has essential features previously established for the F protein of virulent NDV strains. These include the presence of three strongly hydrophobic regions and pairs of dibasic amino acids in the pentapeptide Arg-Arg-Gln-Arg-Arg preceding the putative cleavage site. When inserted into a fowlpox virus vector, a glycosylated protein was expressed and presented on the surface of infected chicken embryo fibroblast cells. The F protein expressed by the recombinant fowlpox virus was cleaved into two polypeptides. When inoculated into susceptible birds by a variety of routes, an immunological response was induced. Ocular or oral administration of the recombinant fowlpox virus gave partial protection, whereas both intramuscular and wing-web routes of inoculation gave complete protection after a single inoculation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157037      PMCID: PMC249277          DOI: 10.1128/JVI.64.4.1441-1450.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Immunization with a vaccinia recombinant expressing the F protein protects rabbits from challenge with a lethal dose of rinderpest virus.

Authors:  T Barrett; G J Belsham; S M Subbarao; S A Evans
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

2.  Nucleotide sequence of the gene encoding the Newcastle disease virus fusion protein and comparisons of paramyxovirus fusion protein sequences.

Authors:  L W McGinnes; T G Morrison
Journal:  Virus Res       Date:  1986-09       Impact factor: 3.303

3.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

6.  Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus.

Authors:  Y Umino; T Kohama; M Kohase; A Sugiura; H D Klenk; R Rott
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

7.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

8.  Construction of recombinant fowlpox viruses as vectors for poultry vaccines.

Authors:  D B Boyle; B E Coupar
Journal:  Virus Res       Date:  1988-06       Impact factor: 3.303

9.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Fusion (F) protein gene of Newcastle disease virus: sequence and hydrophobicity comparative analysis between virulent and avirulent strains.

Authors:  L Le; R Brasseur; C Wemers; G Meulemans; A Burny
Journal:  Virus Genes       Date:  1988-07       Impact factor: 2.332

View more
  25 in total

1.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge.

Authors:  C Letellier; A Burny; G Meulemans
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Identification and DNA sequence analysis of the Marek's disease virus serotype 2 genes homologous to the thymidine kinase and UL24 genes of herpes simplex virus type 1.

Authors:  Y Shimojima; H K Jang; M Ono; K Maeda; Y Tohya; T Mikami
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

5.  Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.

Authors:  J Benson; C Chougnet; M Robert-Guroff; D Montefiori; P Markham; G Shearer; R C Gallo; M Cranage; E Paoletti; K Limbach; D Venzon; J Tartaglia; G Franchini
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 6.  Non-replicating expression vectors: applications in vaccine development and gene therapy.

Authors:  K J Limbach; E Paoletti
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

7.  Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope.

Authors:  Teshome Mebatsion; Marck J M Koolen; Leonie T C de Vaan; Niels de Haas; Marian Braber; Angela Römer-Oberdörfer; Paul van den Elzen; Pieter van der Marel
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Potential use of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed in Rachiplusia nu larvae as an immunogen for chickens.

Authors:  Silvina Chimeno Zoth; Evangelina Gómez; Juan Manuel Carballeda; Oscar Taboga; Elisa Carrillo; Analía Berinstein
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

9.  Role of the TK+ phenotype in the stability of pigeonpox virus recombinant.

Authors:  C Letellier
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins.

Authors:  Youn-Jeong Lee; Haan-Woo Sung; Jun-Gu Choi; Eun-Kyoung Lee; Hachung Yoon; Jae-Hong Kim; Chang-Seon Song
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.